Why the study?
Does the presence and anteroseptal location of Late Gadolinium Enhancement (LGE) on baseline cardiovascular magnetic resonance predict adverse cardiac outcomes in patients with myocarditis?
Does the presence and anteroseptal location of Late Gadolinium Enhancement (LGE) on baseline cardiovascular magnetic resonance predict adverse cardiac outcomes in patients with myocarditis?
Baseline cardiovascular magnetic resonance showing LGE presence and anteroseptal location identifies myocarditis patients at increased risk for adverse cardiac outcomes.
Answers are grounded in this paper and cite their sources.
May guide risk stratification and surveillance in acute myocarditis; supports LGE as independent prognostic marker but needs prospective validation.
LGE presence and anteroseptal location at baseline cardiovascular magnetic resonance are important independent prognostic markers that herald an increased risk of adverse cardiac outcomes in patients with AM. Registration: https://www.crd.york.ac.uk/PROSPERO/ Unique identifier: CRD42019146619.
No takes yet. Share an insight, caveat, or question.
Georgiopoulos et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: